The Cochran Firm Legal Blog

A group of Harvard researchers recently released a study to be published by the American Diabetes Association that lends support to the mounting allegations against the drug Avandia. The study, which analyzed clinical care data from 26,375 diabetes patients between 2000 and 2006, found that diabetic patients taking Avandia suffered more than twice as many heart attacks as patients taking other diabetes medications.

This figure is higher than the study sponsored by GlaxoSmithKline, the pharmaceutical company that produces Avandia. The GlaxoSmithKline study revealed that Avandia users have a 35-41% greater likelihood of suffering a heart attack compared with users of other diabetes medications.

The Harvard study provides compelling evidence that taking Avandia does in fact place a patient at a greater risk for heart attacks. Yet surprisingly, Avandia has not been taken off the market.

More than 13,000 Avandia users have filed pharmaceutical injury lawsuits against the company after suffering heart attacks and other serious injuries caused by taking the dangerous drug. The lawsuits claim that GlaxoSmithKline failed to adequately warn patients of the increased risk of heart attack, heart failure, and stroke.

If you have suffered a serious injury as a result of taking Avandia, the defective drug lawyers at The Cochran Firm can help you receive the compensation you deserve. Please contact us today to schedule your free initial consultation. The Cochran Firm serves clients nationwide.